His primary scientific interests are in Primary biliary cirrhosis, Immunology, Internal medicine, Autoimmune disease and Gastroenterology. His Primary biliary cirrhosis research includes themes of Anti-nuclear antibody, Antigen, Pathology, Primary sclerosing cholangitis and Genotype. His Immunology study often links to related topics such as Cell biology.
Internal medicine is frequently linked to Surgery in his study. The study incorporates disciplines such as Liver transplantation, Biliary cirrhosis, Intensive care medicine, Obeticholic acid and Heterogeneous group in addition to Gastroenterology. His Immune system research incorporates elements of microRNA and Pathogenesis.
The scientist’s investigation covers issues in Primary biliary cirrhosis, Internal medicine, Immunology, Gastroenterology and Autoimmunity. His Primary biliary cirrhosis research focuses on Cirrhosis and how it relates to Epidemiology. In Internal medicine, Pietro Invernizzi works on issues like Endocrinology, which are connected to Cancer research.
His research is interdisciplinary, bridging the disciplines of Disease and Immunology. The Disease study combines topics in areas such as Pathogenesis and Intensive care medicine. The various areas that Pietro Invernizzi examines in his Gastroenterology study include Liver transplantation, Biliary cirrhosis, Obeticholic acid and Cohort.
Pietro Invernizzi mainly investigates Internal medicine, Gastroenterology, Intensive care medicine, Disease and In patient. His Internal medicine research is multidisciplinary, relying on both Oncology and Alkaline phosphatase. His Gastroenterology study combines topics from a wide range of disciplines, such as Primary sclerosing cholangitis, Cohort and Receiver operating characteristic.
His research in Intensive care medicine intersects with topics in Liver disease, Precision medicine, Serum transaminase and Transplantation. His studies in Disease integrate themes in fields like Genetics, Genome-wide association study, Isocitrate dehydrogenase, Clinical trial and Tumor microenvironment. Autoimmunity is the subject of his research, which falls under Immunology.
His main research concerns Internal medicine, Disease, Cirrhosis, Autoimmune hepatitis and Stem cell. His research ties Endocrinology and Internal medicine together. His Disease research integrates issues from Genome-wide association study, Tumor microenvironment, Case-control study, Respiratory failure and Meta-analysis.
He interconnects Liver transplantation, Liver function tests, Mortality rate, Hepatitis and Risk factor in the investigation of issues within Cirrhosis. His Autoimmune hepatitis research incorporates themes from Biodistribution, Dexamethasone and Pharmacology, Drug. His studies deal with areas such as Liver cancer, Cancer cell, Ferroptosis and Metabolism as well as Stem cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis
F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser.
The New England Journal of Medicine (2016)
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
David Ellinghaus;Frauke Degenhardt;Luis Bujanda;Maria Buti.
The New England Journal of Medicine (2020)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield;Ulrich Beuers;Christophe Corpechot;Pietro Invernizzi.
Journal of Hepatology (2017)
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales;Vincenzo Cardinale;Guido Carpino;Marco Marzioni.
Nature Reviews Gastroenterology & Hepatology (2016)
Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment ☆
Carlo F Selmi;Carlo F Selmi;Marlyn J. Mayo;Nancy Bach;Hiromi Ishibashi.
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
Xiangdong Liu;Pietro Invernizzi;Yue Lu;Roman Kosoy.
Nature Genetics (2010)
Macrophage plasticity and polarization in liver homeostasis and pathology
Antonio Sica;Pietro Invernizzi;Alberto Mantovani.
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study
Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen.
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus.
Nature Genetics (2013)
Comparison of the clinical features and clinical course of antimitochondrial antibody‐positive and ‐negative primary biliary cirrhosis
P Invernizzi;A Crosignani;P M Battezzati;G Covini.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: